We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Venous Thromboembolism Taskforce Audit Program

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00535171
First Posted: September 26, 2007
Last Update Posted: January 22, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Sanofi
  Purpose

To determine the effect of an interventional campaign run by a dedicated "VTE Nurse Educator" over a 6-month period and the effect on prophylaxis rates.

To determine the proportion of medically admitted patients with risk factors for VTE.

To assess and compare the use of venous thromboembolism (VTE) prophylaxis in hospitalized medical patients versus recommendations and current guidelines.

To determine the patient characteristics of those deemed to be at risk of VTE. To determine the proportion of patients receiving appropriate thromboprophylaxis for their risk.

To determine the type and duration (where possible) of prophylaxis used.


Condition
Venous Thrombosis

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Venous Thromboembolism Taskforce Audit Program

Further study details as provided by Sanofi:

Enrollment: 8764
Study Start Date: June 2007
Primary Completion Date: August 2008 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Venous thromboembolism in medical patients bedridden due to acute illness.
Criteria

Inclusion Criteria:

  • Hospital admission for an acute illness with an in-patient hospital stay of 3 days or more.

Exclusion Criteria:

  • Patients who have undergone any type of surgery during current admission
  • Patients who are admitted to a ward or department that is excluded from this study e.g psychiatric, paediatric, maternity, intensive care unit, coronary care unit.
  • Prior enrollment in this protocol during current admission
  • Prior enrollment in a VTE study involving pharmaceutical or mechanical treatment within last 90 days.
  • Admission for suspected or diagnosed deep vein thrombosis

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00535171


Locations
Australia
Sanofi-Aventis
MacQuarie Park, Australia
Sponsors and Collaborators
Sanofi
Investigators
Study Director: Fiona Howard Sanofi
  More Information

Responsible Party: Medical Affairs Study Director, sanofi-aventis
ClinicalTrials.gov Identifier: NCT00535171     History of Changes
Other Study ID Numbers: DIREG_L_01927
First Submitted: September 25, 2007
First Posted: September 26, 2007
Last Update Posted: January 22, 2010
Last Verified: January 2010

Additional relevant MeSH terms:
Thrombosis
Thromboembolism
Venous Thromboembolism
Venous Thrombosis
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases